MCID: CNG021
MIFTS: 48

Congenital Toxoplasmosis malady

Categories: Rare diseases, Fetal diseases, Neuronal diseases, Infectious diseases

Aliases & Classifications for Congenital Toxoplasmosis

About this section
Sources:
11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Congenital Toxoplasmosis:

Name: Congenital Toxoplasmosis 11 48 54 13
Toxoplasmosis, Congenital 39 68
Toxoplasma Embryofetopathy 54
 
Toxoplasmosis Congenital 50
Toxoplasmosis - Congen. 11
Toxoplasma Embryopathy 54

Characteristics:

Orphanet epidemiological data:

54
congenital toxoplasmosis:
Inheritance: Not applicable; Prevalence: 1-5/10000 (Europe),1-5/10000 (United States); Age of onset: Adolescent,Adult,Antenatal,Childhood,Infancy,Neonatal

Classifications:



External Ids:

Disease Ontology11 DOID:13336
ICD1030 P37.1
MeSH39 D014125
NCIt45 C50503
Orphanet54 ORPHA858
ICD10 via Orphanet31 P37.1
MESH via Orphanet40 D014125
UMLS via Orphanet69 C0040560

Summaries for Congenital Toxoplasmosis

About this section
Disease Ontology:11 A toxoplasmosis that involves a reactivated infection of the mother transmitted to the fetus during pregnancy. Spontaneous abortion and stillbirth may occur.

MalaCards based summary: Congenital Toxoplasmosis, also known as toxoplasmosis, congenital, is related to toxoplasmosis and alcoholic neuropathy, and has symptoms including Array, Array and Array. An important gene associated with Congenital Toxoplasmosis is CD40LG (CD40 Ligand), and among its related pathways are Primary immunodeficiency and T Cell Co-Signaling Pathway: Ligand-Receptor Interactions. Affiliated tissues include testes, brain and eye.

Related Diseases for Congenital Toxoplasmosis

About this section

Diseases in the Toxoplasmosis family:

congenital toxoplasmosis

Diseases related to Congenital Toxoplasmosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 186)
idRelated DiseaseScoreTop Affiliating Genes
1toxoplasmosis11.5
2alcoholic neuropathy10.3CD40LG, CD79A
3camptodactyly vertebral fusion10.3CD40LG, CD79A
4spinal polio10.3CD40LG, CD79A
5rabies10.3CD40LG, CD79A
6unilateral retinoblastoma10.3CD40LG, CD79A
7mesangial proliferative glomerulonephritis10.3CD40LG, CD79A
8delta chain disease10.3CD40LG, CD79A
9discitis10.3CD40LG, CD79A
10spinal canal and spinal cord meningioma10.3CD40LG, CD79A
11trichostrongyloidiasis10.3CD40LG, CD79A
12colloid adenoma10.3CD40LG, CD79A
13heart septal defect10.3CD40LG, CD79A
14cutaneous polyarteritis nodosa10.3CD40LG, CD79A
15mild pre-eclampsia10.3CD40LG, CD79A
16retinal microaneurysm10.3CD40LG, CD79A
17pediatric meningioma10.3CD40LG, CD79A
18tonsil cancer10.3CD40LG, CD79A
19indomethacin antenatal infection10.3CD40LG, CD79A
20postcricoid region cancer10.3CD40LG, CD79A
21beach ear10.3CD40LG, CD79A
22acute kidney tubular necrosis10.3CD40LG, CD79A
23atheroembolism of kidney10.3CD40LG, CD79A
24partial sensory epilepsy10.3CD40LG, CD79A
25ritscher-schinzel syndrome 110.3CD40LG, CD79A
26diabetic angiopathy10.3CD40LG, CD79A
27endocarditis10.3CD40LG, CD79A
28muscular dystrophy10.3CD40LG, CD79A
29dumping syndrome10.3CD40LG, CD79A
30striatonigral degeneration10.3CD40LG, CD79A
31ciliary body spindle cell melanoma10.3CD40LG, CD79A
32purulent endophthalmitis10.3CD40LG, CD79A
33mu chain disease10.3CD40LG, CD79A
34generalized atherosclerosis10.3CD40LG, CD79A
35bursitis10.3CD40LG, CD79A
36syphilis10.3CD40LG, CD79A
37homocystinuria10.3CD40LG, CD79A
38mental retardation, autosomal dominant 1910.3CD40LG, CD79A
39hemangioma of orbit10.3CD40LG, CD79A
40leiomyosarcoma10.3CD40LG, CD79A
41immunoglobulin beta deficiency10.3CD40LG, CD79A
42gestational diabetes10.3CD40LG, CD79A
43chronic mucocutaneous candidiasis10.3CD40LG, CD79A
44primary thrombocytopenia10.3CD40LG, CD79A
45alkhurma hemorrhagic fever10.3CD40LG, CD79A
46polyneuropathy due to drug10.3CD40LG, CD79A
47colonic benign neoplasm10.3CD40LG, CD79A
48cutaneous ganglioneuroma10.3CD40LG, CD79A
49ovarian serous cystadenocarcinoma10.3CD40LG, CD79A
50coronary artery dissection, spontaneous10.3CD40LG, CD79A

Graphical network of the top 20 diseases related to Congenital Toxoplasmosis:



Diseases related to congenital toxoplasmosis

Symptoms & Phenotypes for Congenital Toxoplasmosis

About this section

Human phenotypes related to Congenital Toxoplasmosis:

 54 64 (show all 26)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hydrocephalus64 54 Occasional (29-5%) HP:0000238
2 microcephaly64 54 Occasional (29-5%) HP:0000252
3 hearing impairment64 54 Occasional (29-5%) HP:0000365
4 visual impairment64 54 Occasional (29-5%) HP:0000505
5 microphthalmia64 54 Occasional (29-5%) HP:0000568
6 nystagmus64 54 Occasional (29-5%) HP:0000639
7 jaundice64 54 Occasional (29-5%) HP:0000952
8 seizures64 54 Occasional (29-5%) HP:0001250
9 muscular hypotonia64 54 Occasional (29-5%) HP:0001252
10 global developmental delay64 54 Occasional (29-5%) HP:0001263
11 intrauterine growth retardation64 54 Occasional (29-5%) HP:0001511
12 failure to thrive in infancy64 54 Occasional (29-5%) HP:0001531
13 ascites64 54 Occasional (29-5%) HP:0001541
14 premature birth64 54 Very frequent (99-80%) HP:0001622
15 cardiomegaly64 54 Occasional (29-5%) HP:0001640
16 thrombocytopenia64 54 Occasional (29-5%) HP:0001873
17 anemia64 54 Occasional (29-5%) HP:0001903
18 diarrhea64 54 Occasional (29-5%) HP:0002014
19 ventriculomegaly64 54 Occasional (29-5%) HP:0002119
20 hepatomegaly64 54 Occasional (29-5%) HP:0002240
21 cerebral calcification64 54 Occasional (29-5%) HP:0002514
22 lymphadenopathy64 54 Occasional (29-5%) HP:0002716
23 elevated hepatic transaminases64 54 Occasional (29-5%) HP:0002910
24 abnormality of retinal pigmentation64 54 Very frequent (99-80%) HP:0007703
25 macule64 54 Occasional (29-5%) HP:0012733
26 cognitive impairment64 54 Occasional (29-5%) HP:0100543

Drugs & Therapeutics for Congenital Toxoplasmosis

About this section

Drugs for Congenital Toxoplasmosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 22)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
LevoleucovorinapprovedPhase 4, Phase 372868538-85-2
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-formyltetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
 
(S)-Leucovorin
Citrovorum factor
L-Folinic acid
Levofolene
Levofolinic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
2
Pyrimethamineapproved, vet_approvedPhase 4, Phase 315758-14-04993
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
46706_FLUKA
46706_RIEDEL
4753 R.P.
4753 r.p
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine
58-14-0
AB00052084
AC-7879
AC1L1JDI
AI3-25005
AZT + Pyrimethamine combination
Aventis Brand of Pyrimethamine
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-K88429204-001-05-4
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 50-63
BW 5063
C07391
C12H13ClN4
CAS-58-14-0
CCRIS 546
CD
CHEBI:8673
CHEMBL36
CID4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
Chloridin
Chloridine
Chloridyn
D00488
D011739
DB00205
Darachlor
Daraclor
Darapram
Daraprim
Daraprim (TN)
Daraprime
Daraprin
Diaminopyritamin
Disulone
DivK1c_000652
EINECS 200-364-2
EXR-101
Erbaprelina
Ethylpyrimidine
Fansidar
Fansidar (Pyrimethamine/Sulfadoxine)
Glaxo Wellcome Brand of Pyrimethamine
GlaxoSmithKline Brand of Pyrimethamine
HMS1568G15
HMS1920N12
HMS2092E13
HMS502A14
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
 
KBio2_006522
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
L000713
LS-238
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
MCB-3837
MLS000028606
MLS001148621
MLS002454446
MLS002701881
Malacid
Malocid
Malocide
Maloprim
MolPort-001-783-655
NCGC00016256-01
NCGC00016256-02
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
NCI-C01683
NCI60_002604
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC-3061
NSC3061
Oxaquin
Pirimecidan
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Prestwick_504
Primethamine
Pyremethamine
Pyrimethamin
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine Hcl
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethaminum
Pyrimethaminum [INN-Latin]
RP 4753
S2006_Selleck
SAM002554921
SMR000058714
SPBio_000672
SPBio_002054
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
Spectrum_000906
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
UNII-Z3614QOX8W
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
Wellcome Brand of Pyrimethamine
ZINC00057464
m alocid
nchembio.215-comp13
nchembio.87-comp22
pyrimethamine
3
SpiramycinapprovedPhase 4, Phase 3424916-50-5
Synonyms:
Demycarosylturimycin H
Foromacidine A
 
Spiramycin 1
Spiramycin A
foromacidin A
4
Sulfadiazineapproved, vet_approvedPhase 4, Phase 33468-35-95215
Synonyms:
141582-64-1
2-Sulfanilamido-pyrimidine
2-Sulfanilamidopyrimidin
2-Sulfanilamidopyrimidin [German]
2-Sulfanilamidopyrimidine
2-Sulfanilylaminopyrimidine
2-Sulfapyrimidine
2-sulfanilamidopyrimidine
2-sulfanilylaminopyrimidine
35033_FLUKA
35033_RIEDEL
4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE
4-Amino-N-(2-pyrimidinyl)benzenesulfonamide
4-Amino-N-2-pyrimidinyl- benzenesulfonamide
4-Amino-N-2-pyrimidinyl-benzenesulfonamide
4-amino-N-(pyrimidin-2-yl)benzenesulfonamide
4-amino-N-2-pyrimidinylbenzenesulfonamide
4-amino-N-pyrimidin-2-ylbenzenesulfonamide
5-25-10-00067 (Beilstein Handbook Reference)
68-35-9
A 306
A-306
A-306 (VAN)
AB00052095
AC-12001
AC1L1JUR
AC1Q51XM
AC1Q6W1E
AI3-01047
AKOS000119073
AR-1L4215
Adiazin
Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine
Adiazine
BB_SC-0628
BPBio1_000095
BRD-K32273377-001-05-4
BRN 0235192
BSPBio_000085
BSPBio_002884
C07658
C10H10N4O2S
CAS-68-35-9
CHEBI:9328
CHEMBL439
CID5215
CRL-8131 & Sulfadiazine
Coco-Diazine
CocoDiazine
Cocodiazine
Codiazine
Cremodiazine
Cremotres
D00587
D013411
DB00359
Debenal
Deltazina
Di-Azo-Mul
Diazin
Diazolone
Diazovit
Diazyl
DivK1c_000543
EINECS 200-685-8
Eskadiazine
HMS1568E07
HMS1921A13
HMS2090P09
HMS2092I15
HMS501L05
Honey Diazine
Honey diazine
IDI1_000543
KBio1_000543
KBio2_001466
KBio2_004034
KBio2_006602
KBio3_002104
KBioGR_000743
KBioSS_001466
LS-147838
Lantrisul
Lipo-Diazine
Lipo-Levazine
Liquadiazine
MLS000069423
Metha-Meridiazine
Microsulfon
Mixture of sulfadiazine, sulfamerazine, and sulfamethazine
MolPort-000-629-738
N(1)-2-Pyrimidinylsulfanilamide
N(1)-2-Pyrimidylsulfanilamide
N(1)-2-pyrimidinylsulfanilamide
N(1)-2-pyrimidylsulfanilamide
N(sup 1)-2-Pyrimidinylsulfanilamide
N(sup1)-2-Pyrimidinylsulfanilamide
N(sup1)-2-Pyrimidylsulfanilamide
N-(2-Pyrimidinyl)sulfanilamide
 
N1-(Pyrimidin-2-yl)sulfanilamide
N1-2-pyrimidinylsulfanilamide
N1-2-pyrimidylsulfanilamide
NCGC00016305-01
NCGC00016305-02
NCGC00023291-03
NCGC00023291-04
NINDS_000543
NSC 35600
NSC117870
NSC35600
Neazine
Neotrizine
Oprea1_081078
Palatrize
Pecta-Diazine
Pecta-diazine, suspension
Piridisir
Pirimal
Prestwick0_000023
Prestwick1_000023
Prestwick2_000023
Prestwick3_000023
Prestwick_428
Pyrimal
Quadetts
Quadramoid
RP 2616
Recombinant bactericidal/permeability-increasing protein & Sulfadiazine
S. N. 112
S.N. 112
S0579
S1770_Selleck
S8626_SIGMA
SDA
SMR000059113
SPBio_001417
SPBio_002006
SPECTRUM1500546
SSD
STK317797
Sanodiazine
Sildaflo
Silvadene
Solfadiazina
Solfadiazina [DCIT]
Spectrum2_001319
Spectrum3_001362
Spectrum4_000342
Spectrum5_000992
Spectrum_000986
Spofadrizine
Sterazine
Sulfa-Triple #2
Sulfacombin
Sulfadiazene
Sulfadiazin
Sulfadiazina
Sulfadiazina [INN-Spanish]
Sulfadiazine
Sulfadiazine (JAN/USP/INN)
Sulfadiazine (TN)
Sulfadiazine [USAN:INN:JAN]
Sulfadiazine, Zinc
Sulfadiazinum
Sulfadiazinum [INN-Latin]
Sulfaloid
Sulfanilamide, N1-2-pyrimidinyl- (8CI)
Sulfanilamidopyrimidine
Sulfapirimidin
Sulfapyrimidin
Sulfapyrimidin [German]
Sulfapyrimidine
Sulfatryl
Sulfazine
Sulfolex
Sulfonamides Duplex
Sulfonsol
Sulfose
Sulphadiazine
Sulphadiazine E
TL80073596
Terfonyl
Theradiazine
Thermazene
Thi-Di-Mer
Tri-Sulfameth
Trifonamide
Triple Sulfa
Triple Sulfas
Triple Sulfoid
Trisem
Trisulfapyrimidine, oral suspension
Truozine
UNII-0N7609K889
WLN: T6N CNJ BMSWR DZ
ZINC00120319
Zinc Sulfadiazine
rBPI21 & Sulfa
sulfadiazine
5
leucovorinapproved, NutraceuticalPhase 4, Phase 3323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
6
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
7Anti-Bacterial AgentsPhase 4, Phase 311226
8Vitamin B ComplexPhase 4, Phase 34337
9Folic Acid AntagonistsPhase 4, Phase 32257
10AntimalarialsPhase 4, Phase 31246
11Anti-Infective AgentsPhase 4, Phase 322062
12Antiprotozoal AgentsPhase 4, Phase 32051
13Antiparasitic AgentsPhase 4, Phase 32199
14Trace ElementsPhase 46001
15AntidotesPhase 41071
16VitaminsPhase 45282
17MicronutrientsPhase 46001
18Calcium, DietaryPhase 45713
19Bone Density Conservation AgentsPhase 43376
20Protective AgentsPhase 47443
21FolateNutraceuticalPhase 4, Phase 34392
22Vitamin B9NutraceuticalPhase 4, Phase 34392

Interventional clinical trials:

idNameStatusNCT IDPhase
1Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisRecruitingNCT00004317Phase 4
2Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital ToxoplasmosisUnknown statusNCT01202500Phase 3
3Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During PregnancyCompletedNCT01189448Phase 3
4Lyon Cohort of Maternal and Congenital Toxoplasma InfectionsRecruitingNCT02936921
5Expanded Noninvasive Genomic Medical Assessment: The Enigma StudyRecruitingNCT02787486

Search NIH Clinical Center for Congenital Toxoplasmosis


Cochrane evidence based reviews: toxoplasmosis, congenital

Genetic Tests for Congenital Toxoplasmosis

About this section

Anatomical Context for Congenital Toxoplasmosis

About this section

MalaCards organs/tissues related to Congenital Toxoplasmosis:

36
Testes, Brain, Eye, Placenta, Temporal lobe, Pituitary, Fetal brain

Publications for Congenital Toxoplasmosis

About this section

Articles related to Congenital Toxoplasmosis:

(show top 50)    (show all 555)
idTitleAuthorsYear
1
Congenital toxoplasmosis: Clinical features, outcomes, treatment, and prevention. (27722099)
2016
2
Outbreak of ovine congenital toxoplasmosis in Iran, confirmed by different diagnostic methods. (27065616)
2016
3
Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis. (27055272)
2016
4
Prenatal and Early Postnatal Diagnosis of Congenital Toxoplasmosis in a Setting With No Systematic Screening in Pregnancy. (26945416)
2016
5
ANTI-TOXOPLASMA ACTIVITY OF ESTRAGOLE AND THYMOL IN MURINE MODELS OF CONGENITAL AND NON-CONGENITAL TOXOPLASMOSIS. (26836848)
2016
6
Prognosis of Fetal Parenchymal Cerebral Lesions without Ventriculomegaly in Congenital Toxoplasmosis Infection. (27093552)
2016
7
Laboratory diagnosis of congenital toxoplasmosis. (27147724)
2016
8
Vertical transmission and fetal damage in animal models of congenital toxoplasmosis: A systematic review. (27198800)
2016
9
Incidence of Symptomatic Congenital Toxoplasmosis During 10 Years in a Brazilian Hospital. (27455439)
2016
10
Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis. (26689954)
2016
11
Ocular manifestation of congenital toxoplasmosis, clinical implication - case report. (27306134)
2016
12
IgA and IgG1 reactivities assessed by flow cytometry mirror clinical aspects of infants with ocular congenital toxoplasmosis. (26592658)
2016
13
Cytokine Signatures Associated With Early Onset, Active Lesions and Late Cicatricial Events of Retinochoroidal Commitment in Infants With Congenital Toxoplasmosis. (26946460)
2016
14
Congenital Toxoplasmosis in Chronically Infected and Subsequently Challenged Ewes. (27788185)
2016
15
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment. (26906163)
2016
16
HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis. (26856406)
2016
17
Possibilities for Immunomodulation in Congenital Toxoplasmosis. (27357341)
2016
18
Evaluation of the western blotting method for the diagnosis of congenital toxoplasmosis. (27504975)
2016
19
Late diagnosis of congenital toxoplasmosis based on serological follow-up: A case report. (27956093)
2016
20
Congenital toxoplasmosis: an uncommon disease in Thailand. (25547178)
2015
21
Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. (25596783)
2015
22
Place of Interferon-I^ Assay for Diagnosis of Congenital Toxoplasmosis. (26780025)
2015
23
Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis. (25651923)
2015
24
Severe congenital toxoplasmosis: a case report and strain characterization. (25685568)
2015
25
Prenatal education for congenital toxoplasmosis. (26493047)
2015
26
Mesial Temporal Lobe Epilepsy in Congenital Toxoplasmosis: A Case Report. (26157672)
2015
27
Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis. (26254559)
2015
28
Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis. (25694528)
2015
29
Congenital toxoplasmosis: an in-depth density-equalizing mapping analysis to explore its global research architecture. (26691532)
2015
30
Congenital toxoplasmosis and pregnancy malaria detection post-partum: Effective diagnosis and its implication for efficient management of congenital infection. (26264261)
2015
31
Congenital Toxoplasmosis: A Review. (26802827)
2015
32
Assessment of the IgA immunosorbent agglutination assay for the diagnosis of congenital toxoplasmosis on a series of 145 toxoplasmic seroconversions. (25673306)
2015
33
The rural-urban effect on spatial genetic structure of type II Toxoplasma gondii strains involved in human congenital toxoplasmosis, France, 2002-2009. (26305624)
2015
34
Evaluation of colostrum as an alternative biological sample for the diagnosis of human congenital toxoplasmosis. (26573138)
2015
35
Rate of congenital toxoplasmosis in large integrated health care setting, California, USA, 1998-2012. (25151860)
2014
36
Congenital toxoplasmosis from a mother with type 2 diabetes mellitus: A case report. (25164320)
2014
37
Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy. (24961630)
2014
38
It is not only the cat that did it: How to prevent and treat congenital toxoplasmosis. (24119928)
2014
39
Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis. (25328286)
2014
40
Utility and limitations of T. gondii-specific IgM serum antibodies in the diagnosis of congenital toxoplasmosis in Porto Alegre. (24726454)
2014
41
Congenital toxoplasmosis presenting as central diabetes insipidus in an infant: a case report. (24674575)
2014
42
Multicentric comparative assessment of the Bio-EvolutionAr Toxoplasma gondii detection kit with eight laboratory-developed PCR assays for the molecular diagnosis of congenital toxoplasmosis. (25339393)
2014
43
Congenital toxoplasmosis in a reference center of ParanA!, Southern Brazil. (24662141)
2014
44
Congenital Toxoplasmosis. (25232475)
2014
45
Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. (24445828)
2014
46
Adverse socioeconomic conditions and oocyst-related factors are associated with congenital toxoplasmosis in a population-based study in Minas Gerais, Brazil. (24523920)
2014
47
Evaluation of a new protocol for retrospective diagnosis of congenital toxoplasmosis by use of Guthrie cards. (24899036)
2014
48
Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis. (24530469)
2014
49
Incidence of congenital toxoplasmosis among infants born to HIV-coinfected mothers: case series and literature review. (25017666)
2014
50
Incidence of death from congenital toxoplasmosis in 0-4-year-old children in Japan. (25252058)
2014

Variations for Congenital Toxoplasmosis

About this section

Expression for genes affiliated with Congenital Toxoplasmosis

About this section
Search GEO for disease gene expression data for Congenital Toxoplasmosis.

Pathways for genes affiliated with Congenital Toxoplasmosis

About this section

Pathways related to Congenital Toxoplasmosis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7CD40LG, CD79A
29.6CD40LG, COL2A1
39.6CD40LG, TLR9
49.6CD40LG, TLR9
58.5CD40LG, CD79A, NLRP1, TLR9

GO Terms for genes affiliated with Congenital Toxoplasmosis

About this section

Biological processes related to Congenital Toxoplasmosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1B cell differentiationGO:003018310.4CD40LG, CD79A
2B cell proliferationGO:004210010.4CD40LG, CD79A
3positive regulation of interleukin-10 productionGO:003273310.2CD40LG, TLR9
4positive regulation of interleukin-12 productionGO:003273510.2CD40LG, TLR9
5inflammatory responseGO:00069549.6CD40LG, NLRP1, TLR9
6visual perceptionGO:00076018.7ABCA4, COL2A1, NRL

Sources for Congenital Toxoplasmosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet